All In MedTech

FDA Clearance Tracker · P140017-S014

Melody TPV System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 18, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 18, 2019

Approved

Time to decision

156 days

Received Nov 13, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P140017-S014
Device name
Melody TPV System
Applicant location
Mounds View, MN
Received
Nov 13, 2018
Decided
Apr 18, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P140017

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for an update to labeling based on the results of your Post-Approval Study.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.